Figure 7.Screening the potential sensitive chemotherapy drugs for HCC. The top 10 most significantly sensitive drugs for the high-risk group (A) and the low-risk group (B), respectively.
Figure 7 — A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma | Aging
